Cargando…

The Regulatory Effect of Firm Size on Digital Transformation: An Empirical Study of Pharmaceutical Companies in China

Digital transformation (DT) has been a key way for pharmaceutical companies to enhance innovation and R&D capabilities, improve product quality, reduce costs, and create competitive advantages. The external environment factors and the internal conditions' factors are the main factors affect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Xiaowen, Yu, Shun-Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550424/ https://www.ncbi.nlm.nih.gov/pubmed/36225542 http://dx.doi.org/10.1155/2022/7731174

Ejemplares similares

Cash flow management and its effect on firm performance: Empirical evidence on non-financial firms of China
por: Laghari, Fahmida, et al.
Publicado: (2023)

Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies
por: Rasekh, Hamid Reza, et al.
Publicado: (2012)

Digital Transformation and Green Innovation of Chinese Firms: The Moderating Role of Regulatory Pressure and International Opportunities
por: He, Jinqiu, et al.
Publicado: (2022)

Characteristics, risk management and GMP standards of pharmaceutical companies in China
por: Chen, Hong, et al.
Publicado: (2023)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

Advancement of cloud-based accounting effectiveness, decision-making quality, and firm performance through digital transformation and digital leadership: Empirical evidence from Vietnam
por: Hung, Bui Quang, et al.
Publicado: (2023)

Organizational performance, Marketing strategy, and Financial strategic alignment: an empirical study on Iranian pharmaceutical firms
por: Mohammadzadeh, Mehdi, et al.
Publicado: (2013)

Impact of Corporate Reputation on Brand Differentiation: An Empirical Study from Iranian Pharmaceutical Companies
por: vahabzadeh, Afshin, et al.
Publicado: (2017)

Economic and non-economic determinants of Iranian pharmaceutical companies’ financial performance: an empirical study
por: Masoumi, Mohammadreza, et al.
Publicado: (2019)

The influence of pharmaceutical companies
por: Migone, Paolo
Publicado: (2017)

Economic Policy Uncertainty and Family Firm Innovation: Evidence From Listed Companies in China
por: Qi, Yong, et al.
Publicado: (2022)

Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies
por: Miller, Jennifer E, et al.
Publicado: (2017)

Digital Transformation and Financial Risk Prediction of Listed Companies
por: Xinxian, Chen, et al.
Publicado: (2022)

CEO Regulatory Focus, Analysts’ Optimism Bias, and Firm Strategic Change: Evidence From Chinese-Listed Companies
por: Huang, Chun, et al.
Publicado: (2022)

Pharmacovigilance in pharmaceutical companies: An overview
por: Mammì, Maria, et al.
Publicado: (2013)

Micro-perspective of listed companies in China: Digital development promotes the green transformation of the manufacturing industry
por: Wang, Haohui, et al.
Publicado: (2023)

Corporate financialization, financing constraints, and innovation efficiency—Empirical evidence based on listed Chinese pharmaceutical companies
por: Zhu, Jialin, et al.
Publicado: (2023)

Digital transformation and total factor productivity: Empirical evidence from China
por: Lei, Zhonghao, et al.
Publicado: (2023)

Digital Transformation and Firm Performance in the Context of Sustainability: Mediating Effects Based on Behavioral Integration
por: Tang, Wei, et al.
Publicado: (2022)

An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies
por: Ye, Rendao, et al.
Publicado: (2021)

Off-label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities
por: Gupta, Sandeep Kumar, et al.
Publicado: (2014)

Empirical analysis of the impact of the digital economy on the green transformation of manufacturing: Evidence from China
por: Jia, Chunjie, et al.
Publicado: (2023)

Pharmacovigilance obligations of the pharmaceutical companies in India
por: Arora, Deepa
Publicado: (2008)

Involvement of pharmaceutical companies at scientific meetings
por: Brink, Andries
Publicado: (2010)

Regulating pharmaceutical companies’ financial largesse
por: Avraham, Ronen, et al.
Publicado: (2018)

The Pharmaceutical Company Approach to Antibiotic Policies
por: White, Anthony R.
Publicado: (2005)

Ethics, gastroenterologists, and pharmaceutical and equipment companies
por: Roberts‐Thomson, Ian C
Publicado: (2020)

Expected Impact of Biosimilars on the Pharmaceutical Companies
por: Golshani, Shiva, et al.
Publicado: (2021)

Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
por: Maeda, Hideki
Publicado: (2021)

Impact of Financing Constraints on Firm Performance: Moderating Effect Based on Firm Size
por: Yao, Yonghong, et al.
Publicado: (2022)

The digital revolution: how connected digital innovations are transforming your industry, company, and career
por: Sidhu, Inder, et al.
Publicado: (2016)

Retracted: Digital Transformation and Firm Performance in the Context of Sustainability: Mediating Effects Based on Behavioral Integration
por: Environmental and Public Health, Journal of
Publicado: (2023)

A study of the factors which influence digital transformation in Kibs companies
por: Marino-Romero, Jorge Alberto, et al.
Publicado: (2022)

Competitive strategy, development zone policy and firm growth: Empirical evidence from China
por: Ye, Kaiyue, et al.
Publicado: (2023)

Association between strategic differentiation and firm leverage manipulation: Empirical evidence from China
por: Niu, Feng, et al.
Publicado: (2023)

An empirical study on the asset-light operation and corporate performance of China's tourism listed companies
por: Liang, Shi, et al.
Publicado: (2023)

How does ESG performance affect stock returns? Empirical evidence from listed companies in China
por: Yin, Xiao-Na, et al.
Publicado: (2023)

Are Founders More Socially Responsible? —An Empirical Research on Private Listed Companies in China
por: Xiaofei, Shi, et al.
Publicado: (2021)

Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies
por: Booth, Amy, et al.
Publicado: (2023)

Firms of Endearment: How World-Class Companies Profit from Passion and Purpose
por: Sisodia, Rajendra
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nh9jdlmpq67re255d7d0gckvfo